Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25630357 | 0.89 | — | — | |
| SCHEMBL499923 | 0.83 | PTGS1 (0.41) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL576422 | 0.81 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL28318417 | 0.80 | FAAH (0.36) | — | |
| Eprodisate SCHEMBL34216 | 0.80 | APP (0.65) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL29104749 | 0.77 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL14975445 | 0.77 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL2701823 | 0.77 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL12878941 | 0.77 | APP (0.44) | APPPTGS1PDE4ALMNASLC6A6 | |
| Eprodisate SCHEMBL23795561 | 0.76 | APP (0.61) | APPPTGS1PDE4ALMNASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102696142-B | Nonaqueous electrolyte solution, electrochemical device using same, and alkynyl compound used in nonaqueous electrolyte solution | UBE INDUSTRIES | 2015-06-03 | — | — | CN | claimed |
| US-7342050-B2 | Method for preparing a lactic acid ester composition and use thereof as solvent | ROQUETTE FRERES (FR) | 2008-03-11 | — | — | US | claimed |
| EP-1614416-A2 | Method for treating amyloidosis | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2006-01-11 | — | — | EP | claimed |
| EP-1060750-B1 | Propane-1,3-disulfonic acid and its pharmaceutically acceptable salts for treating amyloidosis | UNIV KINGSTON (CA) | 2005-12-07 | — | — | EP | claimed |
| EP-1242357-B1 | METHOD FOR PREPARING A LACTIC ACID ESTER COMPOSITION AND USE THEREOF AS SOLVENT | ROQUETTE FRERES (FR) | 2004-07-21 | — | — | EP | claimed |
| US-20030008927-A1 | Method for preparing a lactic acid ester composition and use thereof as solvent | ROQUETTE FRERES (FR) | 2003-01-09 | — | — | US | claimed |
| US-20230352250-A1 | PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION MODULE, ELECTRONIC DEVICE, AND POWER SUPPLY MODULE | RICOH COMPANY, LTD. (JP) | 2023-11-02 | — | — | US | disclosed |
| US-20230343965-A1 | SECONDARY BATTERY | MURATA MANUFACTURING CO (JP) | 2023-10-26 | — | — | US | disclosed |
| US-20230246229-A1 | ORGANIC SULFONATE ELECTROLYTE ADDITIVES FOR ZINC BATTERIES | Octet Scientific, Inc. | 2023-08-03 | — | — | US | disclosed |
| US-20230246229-A1 | ORGANIC SULFONATE ELECTROLYTE ADDITIVES FOR ZINC BATTERIES | Octet Scientific, Inc. | 2023-08-03 | — | — | US | disclosed |
| US-20230198021-A1 | ELECTROLYTIC SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2023-06-22 | — | — | US | disclosed |
| US-20230165877-A1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | WISTA LABORATORIES LTD. (SG) | 2023-06-01 | — | — | US | disclosed |
| US-20210226242-A1 | Systems, Devices, and/or Methods for Fuel Cell Utilizing Reactive Nano Silicate | HK INVENT CORPORATION (VN) | 2021-07-22 | — | — | US | disclosed |
| WO-2006008661-A2 | DIAGNOSTIC METHODS OF MULTIPLE ORGAN AMYLOIDOSIS | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2006-01-26 | — | — | WO | disclosed |
| EP-1614416-A2 | Method for treating amyloidosis | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2006-01-11 | — | — | EP | disclosed |
| EP-1060750-B1 | Propane-1,3-disulfonic acid and its pharmaceutically acceptable salts for treating amyloidosis | UNIV KINGSTON (CA) | 2005-12-07 | — | — | EP | disclosed |
| US-20030008927-A1 | Method for preparing a lactic acid ester composition and use thereof as solvent | ROQUETTE FRERES (FR) | 2003-01-09 | — | — | US | disclosed |
| EP-1060750-A2 | Method for treating amyloidosis | Queen's University at Kingston (CA) | 2000-12-20 | — | — | EP | disclosed |
| EP-0691844-A1 | METHOD FOR TREATING AMYLOIDOSIS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1996-01-17 | — | — | EP | disclosed |
| WO-1994022437-A2 | METHOD FOR TREATING AMYLOIDOSIS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1994-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165877-A1 | ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES | ACHE, BCHE, PNMT | APP 111/4885PTGS1 3666/4885PDE4A 759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.